Liensinine alleviates type 2 diabetes mellitus through modulating the pancreatic β cell function and gut microbiota
Yunfei Luo, Xuchang Liu, Yan Zhang, Jiaxin Wu, Yujie Wang, Jing Nie, Ying Ying, Shibo Huang · 2025
Read Liensinine alleviates type 2 diabetes mellitus through modulating the pancreatic β cell function and gut microbiota by Yunfei Luo, Xuchang Liu, Yan Zhang, Jiaxin Wu, Yujie Wang, Jing Nie, Ying Ying, Shibo Huang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729215.txt.
Description
Yunfei Luo and co-authors test a plant compound against diabetes in mice in this 2025 study. Liensinine comes from lotus seeds and is used in herbal practice. Its effect on blood sugar was poorly understood. The team fed mice a high-fat diet and used a drug to trigger type 2 diabetes. Some mice then received the compound daily.
Treated mice showed less damage in the pancreas and liver. Their insulin-making cell groups regained a healthier shape and balance. The compound also shifted gut bacteria toward types linked with better metabolism. Gut output of helpful fatty acids rose as well. The authors present liensinine as a candidate worth further study.
Catalog record
| CREATOR | Yunfei Luo, Xuchang Liu, Yan Zhang, Jiaxin Wu, Yujie Wang, Jing Nie, Ying Ying, Shibo Huang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |